Lalitpur, Bagmati Province, Kathmandu, Nepal.
Department of Biostatistics, Vallabhbhai Patel Chest Institute, University of Delhi, New Delhi, India.
Int J Gynaecol Obstet. 2024 Aug;166(2):483-493. doi: 10.1002/ijgo.15366. Epub 2024 Jan 24.
Cervical cancer is a preventable cancer by screening, vaccination and timely management of preinvasive cervical lesions. However, about 90% of the global burden of cervical cancer is reported from developing countries.
This systematic review aimed to analyze the strategies implemented for cervical cancer screening in South Asia.
An electronic search of PubMed/MEDLINE, Scopus and Google Scholar was carried out for articles published in English, evaluating the implementation of cervical cancer screening between December 2000 and June 2023 in South Asia using appropriate search terms.
Cross-sectional studies, randomized control trials (RCTs) or non-randomized controlled trials evaluating different cervical screening strategies were included.
A three-stage selection process was performed using a validated proforma including the title, author, year of publication, objective, country, study design, screening methods, strategies and outcomes, and results. The systematic review was designed based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The risk of bias was evaluated with the National Heart, Lung, and Blood Institute's (NHLBI) Quality Assessment Tools.
Out of the initial 1135 articles reviewed systematically, 23 studies met the inclusion criteria and were included in the qualitative synthesis of results. The implementation outcomes measured were acceptability (n = 23 100%), feasibility (n = 22, 95.7%), fidelity (n = 14, 60.9%), sustainability (n = 7, 30.4%), coverage (n = 4, 17.4%) and cost (n = 1, 4.3%).
Cervical cancer screening can be effectively implemented by restructuring the ongoing programs.
宫颈癌可以通过筛查、疫苗接种和及时管理癌前宫颈病变来预防。然而,全球 90%左右的宫颈癌负担发生在发展中国家。
本系统评价旨在分析南亚实施宫颈癌筛查的策略。
对 PubMed/MEDLINE、Scopus 和 Google Scholar 进行电子检索,检索时间为 2000 年 12 月至 2023 年 6 月,使用适当的检索词评估在南亚实施宫颈癌筛查的情况。
纳入评估不同宫颈癌筛查策略的横断面研究、随机对照试验(RCT)或非随机对照试验。
采用经过验证的方案,分三个阶段进行选择过程,包括标题、作者、出版年份、目标、国家、研究设计、筛查方法、策略和结果以及结果。该系统评价是根据系统评价和荟萃分析的首选报告项目(PRISMA)指南设计的。使用国家心肺血液研究所(NHLBI)质量评估工具评估偏倚风险。
在系统审查的 1135 篇文章中,有 23 项研究符合纳入标准,并纳入了结果的定性综合分析。评估的实施结果包括可接受性(n=23100%)、可行性(n=22,95.7%)、保真度(n=14,60.9%)、可持续性(n=7,30.4%)、覆盖率(n=4,17.4%)和成本(n=1,4.3%)。
通过重组现有的项目,可以有效地实施宫颈癌筛查。